Aclaris Therapeutics, Inc. (ACRS) Net margin 2017–2025
Aclaris Therapeutics, Inc. (ACRS) net profit margin by fiscal year — reported net income divided by reported revenue.
-829.6%FY2025 · since FY2017: -4071.5% → -829.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -829.6% | -124.1 pp |
| FY2024 | -705.5% | -422.3 pp |
| FY2023 | -283.1% | +9.0 pp |
| FY2022 | -292.1% | +1051.8 pp |
| FY2021 | -1344.0% | -556.9 pp |
| FY2020 | -787.0% | +3030.2 pp |
| FY2019 | -3817.2% | -1659.2 pp |
| FY2018 | -2158.0% | +1913.5 pp |
| FY2017 | -4071.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice